Previous Close | 12.14 |
1-Year Change | 134.36% |
6-Months Change | 33.11% |
3-Months Change | 5.47% |
Moving Avg (50d) | 10.845 |
Moving Avg (200d) | 8.827 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.766B |
Beta (3-Years) | 1.56 |
Revenue Growth (ttm) | 19.73% |
Net Profit Margin (ttm) | -2.13% |
Return On Assets (ttm) | -0.72% |
EPS (ttm) | -0.05 |
PE Ratio (ttm) | -242.8 |
Dividend Yield | % |
Asset Description: | Avid Bioservices, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-11-04 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
11.976 | 11.609 | 11.365 | 10.998 | 10.387 | 9.776 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |